Streetbeat News

Stock Prices

CAH

Cardinal Health has updated its FY24 adjusted EPS guidance to the higher end of the $6.75-$7.00 range, exceeding the $6.95 estimate. The company also plans to execute a new $250M accelerated share repurchase program in Q2. Cardinal Health reiterated its long-term targets, aiming for a 12%-14% growth in adjusted EPS. The update is attributed to strong cash flow generation leading to higher cash balances and favorable fiscal conditions.

Portfolio Pulse from Benzinga Newsdesk

January 09, 2024 | 11:52 am

ALL

Jefferies analyst Yaron Kinar has upgraded Allstate (NYSE:ALL) from Hold to Buy and increased the price target from $130 to $180, indicating a positive outlook for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

January 09, 2024 | 11:51 am

DKNG

BMO Capital analyst Brian Pitz has initiated coverage on DraftKings (NASDAQ:DKNG) with an Outperform rating and set a price target of $43.

Portfolio Pulse from Benzinga Newsdesk

January 09, 2024 | 11:41 am

CYBR

GRFS

HOLX

HPE

HRTX

JNPR

MCHP

NKTX

PRTA

SMMT

U.S. stock futures are down, with Dow Jones futures dropping about 100 points. Hewlett Packard Enterprise (HPE) shares fell 8.5% in pre-market trading amid reports of a potential acquisition of Juniper Networks (JNPR) for approximately $13 billion. Other stocks experiencing pre-market losses include Grifols (GRFS), CyberArk Software (CYBR), Summit Therapeutics (SMMT), Nkarta (NKTX), Hologic (HOLX), Microchip Technology (MCHP), Prothena Corporation (PRTA), and Heron Therapeutics (HRTX).

Portfolio Pulse from Avi Kapoor

January 09, 2024 | 11:36 am

NARI

Inari Medical announced preliminary unaudited revenue for Q4 2023 of at least $132M, a 22% increase year-over-year, surpassing the consensus estimate of $130.98M. The company also reported preliminary unaudited revenue for FY23 of at least $493.5M, a 29% increase year-over-year, slightly above the consensus estimate of $492.61M.

Portfolio Pulse from Benzinga Newsdesk

January 09, 2024 | 11:35 am

SKLZ

Skillz Inc. has announced that Jason Roswig will step down as CFO. Gaetano Franceschi has been appointed as the new CFO, according to an 8-K filing.

Portfolio Pulse from Charles Gross

January 09, 2024 | 11:33 am

AYI

Acuity Brands (NYSE:AYI) reported Q1 earnings with an EPS of $3.72, beating estimates by 15.17% but with a revenue decrease of $63.20 million from the previous year. The company had previously beaten EPS estimates last quarter, which did not affect the share price the following day.

Portfolio Pulse from Benzinga Insights

January 09, 2024 | 11:10 am

FLNG

Flex LNG announced that its Flex Constellation ship will return in Q2 2024 after the charterer decided not to extend the charter option. This news follows an earlier report on Monday.

Portfolio Pulse from Charles Gross

January 09, 2024 | 11:09 am

ELTX

Elicio Therapeutics has published data from its Phase 1 AMPLIFY-201 study of ELI-002 2P in solid tumors in Nature Medicine. The results show that ELI-002, as a monotherapy, induced strong and lasting T cell responses and led to tumor biomarker reduction in 84% of patients. This correlated with a median relapse-free survival of 16.3 months. A Phase 2 trial for ELI-002 in pancreatic ductal adenocarcinoma is set to begin in early 2024.

Portfolio Pulse from Benzinga Newsdesk

January 09, 2024 | 11:03 am

AYI

Acuity Brands reported Q1 adjusted EPS of $3.72, surpassing the $3.23 estimate by 15.17%, and a 13.07% increase from last year's $3.29 per share. However, sales of $934.70M slightly missed the $935.14M estimate by 0.05%, marking a 6.33% decrease from the previous year's $997.90M.

Portfolio Pulse from Benzinga Newsdesk

January 09, 2024 | 11:03 am